SOLVATE AND CRYSTALLINE FORMS OF TRANS-1-{4-[2-[4-(2,3-DICHLOROPHENYL)PIPERAZINE-1-YL]ETHYL]CYCLOHEXYL}-3,3-DIMETHYLUREA HYDROCHLORIDE, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING CONDITIONS WHICH REQUIRE MODULATION OF DOPAMINE RECEPTORS

摘要

The present invention relates to novel solvate and crystalline forms of trans-1-{4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl}-3,3-dimethylurea hydrochloride. Processes for preparing and use thereof in pharmaceutical compositions and methods for treating conditions which require modulation of dopamine receptors.